Clinical Trial Update: 11C-5-HTP PET in Clinical Islet Transplantation [NA]

View source ↗

Summary

Clinical trial update for 11C-5-HTP PET imaging in islet transplantation for type 1 diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• 11C-5-HTP PET tracer (11C-5-hydroxytryptophan PET tracer)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes | NA | Status: COMPLETED